Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial. Groupe Régional d'Etude du Cancer Colo-Rectal (Belgium).

Focan, C

Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial. Groupe Régional d'Etude du Cancer Colo-Rectal (Belgium). [electronic resource] - Anti-cancer drugs Aug 2000 - 549-54 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0959-4973

10.1097/00001813-200008000-00005 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Chemotherapy, Adjuvant
Colorectal Neoplasms--drug therapy
Disease-Free Survival
Female
Fluorouracil--administration & dosage
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Middle Aged
Mitomycin--administration & dosage
Neoplasm Metastasis
Neoplasm Recurrence, Local
Portal Vein